Blockchain Registration Transaction Record

DecisionRx Study: Pharmacist-Led Program Cuts Medicare ACO Costs by 31.9%

DecisionRx study shows pharmacist-led medication optimization cuts Medicare ACO costs by 31.9%, reducing hospitalizations and ER visits. Learn more.

This news matters because it demonstrates a tangible, scalable solution to one of the most persistent challenges in healthcare: the high cost of medication failure. With medication-related problems driving unnecessary emergency visits, hospitalizations, and spending among Medicare beneficiaries, DecisionRx's MTO program offers a proven method to reduce costs while improving care. The study's strong statistical significance and dose-response pattern suggest that integrating clinical pharmacists and pharmacogenomic testing into value-based care models could lead to substantial savings for payers and better outcomes for patients. As healthcare systems increasingly seek ways to optimize spending without compromising quality, this evidence supports broader adoption of pharmacist-led medication optimization.